Inger Byrjalsen
- LATE-BREAKING ABSTRACT: Biomarkers of extracellular matrix turnover predict mortality in the ECLIPSE COPD cohortBy Jannie M.B. Sand, Diana Julie Leeming, Inger Byrjalsen, Asger Bihlet, Ruth Tal-Singer, Bruce E. Miller, Morten A. Karsdal and Jørgen VestboJannie M.B. Sand1Fibrosis Biology and Biomarkers, Nordic Bioscience, Herlev, Denmark2Section of Social Medicine, Institute of Public Health, University of Copenhagen, Copenhagen, DenmarkDiana Julie Leeming1Fibrosis Biology and Biomarkers, Nordic Bioscience, Herlev, DenmarkInger Byrjalsen1Fibrosis Biology and Biomarkers, Nordic Bioscience, Herlev, DenmarkAsger Bihlet1Fibrosis Biology and Biomarkers, Nordic Bioscience, Herlev, DenmarkRuth Tal-Singer3R&D, GSK, on Behalf of The Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) Study Investigators, King of Prussia, PA United StatesBruce E. Miller3R&D, GSK, on Behalf of The Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) Study Investigators, King of Prussia, PA United StatesMorten A. Karsdal1Fibrosis Biology and Biomarkers, Nordic Bioscience, Herlev, DenmarkJørgen Vestbo4Centre for Respiratory Medicine and Allergy, Manchester Academic Science Centre, The University of Manchester and University Hospital South Manchester NHS Foundation Trust, on Behalf of The Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) Study Investigators, Manchester, United Kingdom
- LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohortBy Diana Julie Leeming, Inger Byrjalsen, Jannie M.B. Sand, Asger Bihlet, Ruth Tal-Singer, Bruce E. Miller, Morten A. Karsdal and Jørgen VestboDiana Julie Leeming1Nordic Bioscience, Fibrosis Biology and Biomarkers, Herlev, DenmarkInger Byrjalsen1Nordic Bioscience, Fibrosis Biology and Biomarkers, Herlev, DenmarkJannie M.B. Sand1Nordic Bioscience, Fibrosis Biology and Biomarkers, Herlev, Denmark2Section of Social Medicine, Institute of Public Health, University of Copenhagen, Copenhagen, DenmarkAsger Bihlet1Nordic Bioscience, Fibrosis Biology and Biomarkers, Herlev, DenmarkRuth Tal-Singer3R&D, GSK, on Behalf of The Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) Study Investigators, King of Prussia, PA United StatesBruce E. Miller3R&D, GSK, on Behalf of The Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) Study Investigators, King of Prussia, PA United StatesMorten A. Karsdal1Nordic Bioscience, Fibrosis Biology and Biomarkers, Herlev, DenmarkJørgen Vestbo4Centre for Respiratory Medicine and Allergy, Manchester Academic Science Centre, The University of Manchester and University Hospital South Manchester NHS Foundation Trust, on Behalf of The Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) Study Investigators, Manchester, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.